diabetes mellitus, type 2

Showing NaN - NaN of 128

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +116 more
Feb 14, 2020

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathy
  • Birmingham, Alabama
  • +592 more
Dec 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Muscle Shoals, Alabama
  • +142 more
Nov 8, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/insulin aspart
  • +2 more
  • Glendale, Arizona
  • +70 more
Nov 8, 2019

Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)

Completed
  • Cardiovascular Disease
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +300 more
Sep 18, 2019

Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Human Insulin Inhalation Powder
  • Insulin Glargine
  • Fresno, California
  • +68 more
Sep 6, 2019

Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin)

Completed
  • Diabetes Mellitus, Type 2
  • Human Insulin Inhalation Powder
  • Insulin
  • Huntington Beach, California
  • +59 more
Sep 6, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Type 2, Diabetes Trial in Russian Federation (Humalog Mix25, Insulin Lispro Biphasic 25)

Completed
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus
  • Humalog Mix25
  • Insulin Lispro Biphasic 25
  • Chelyabinsk, Russian Federation
  • +17 more
Jul 16, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Type 2 Trial in Russian Federation (Insulin Humulin® NPH, Insulin Rinsulin® NPH)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Humulin® NPH
  • Insulin Rinsulin® NPH
  • Chelyabinsk, Russian Federation
  • +13 more
Jul 8, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Buenos Aires, Argentina
  • +140 more
May 28, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Type 2, Diabetes Complications Trial in Moscow (Cocarnit)

Completed
  • Diabetes Mellitus, Type 2
  • Diabetes Complications
  • Cocarnit
  • Moscow, Russian Federation
    Institute for Atherosclerosis Research
Mar 19, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +96 more
Mar 6, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +2 more
  • Glendale, Arizona
  • +143 more
Jan 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Fresno, California
  • +90 more
Dec 7, 2018

Hypoglycaemia Among Insulin-treated Patients With Diabetes

Completed
  • Diabetes
  • +2 more
  • No treatment given
  • Prov. De Buenos Aires, Argentina
  • +23 more
Dec 7, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in Worldwide (SRT2104, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Byala, Bulgaria
  • +60 more
May 2, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, insulin glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Idaho Falls, Idaho
  • +24 more
May 4, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin Glargine, Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +155 more
Mar 16, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Tuscumbia, Alabama
  • +116 more
Mar 1, 2018